Philip Morris ordered to pay Australia for costs of defending tobacco plain packaging investment challenge

Thursday 27 July, 2017
by Suzanne Zhou

 

 

Plain tobacco packaging in Australia. Source: Shutterstock
Plain tobacco packaging in Australia. Source: Shutterstock

 

On 13 July 2017, the tribunal constituted to hear Philip Morris Asia Ltd’s (PMA) investment treaty challenge against Australia’s tobacco plain packaging laws ordered PMA to reimburse Australia for costs involved in defending the case.

The dispute, brought by PMA under the 1993 Hong Kong – Australia bilateral investment treaty, was decided in favour of Australia in 2015. In its Award on Jurisdiction and Admissibility, released in May 2016, the tribunal concluded that it was precluded from exercising jurisdiction over the dispute. It found that:

‘the initiation of this arbitration constitutes an abuse of rights, as the corporate restructuring by which the Claimant acquired the Australian subsidiaries occurred at a time when there was a reasonable prospect that the dispute would materialise and as it was carried out for the principal, if not sole, purpose of gaining Treaty protection.’

The Tribunal's Final Award Regarding Costs considers and dismisses PMA’s argument that it should not pay Australia and the Tribunal’s costs.

‘Loser pays’ rule should apply

The default rule under the relevant procedural rules is that the ‘loser’ pays the costs of the dispute, including the legal costs of the other party and the Tribunal’s expenses. The Tribunal may decide to otherwise apportion the costs if it is ‘reasonable’ to do so.

PMA had argued that it was “not correct or appropriate to label one party the ‘winner’ and one party the ‘loser’”, because PMA had prevailed on two arguments and lost on two arguments.

The Tribunal disagreed, finding that the ‘loser’ of an investment dispute was the party that had been unsuccessful, assessed in light of the overall outcome of the case. Here, PMA’s claim had been dismissed and it had been found to have abused its rights. The Tribunal emphasised that ‘a respondent State that faces an abuse of right should, in principle, not be burdened with the costs of defending itself against such a claim.’

The Tribunal reduced the amount that would otherwise have been payable by PMA by a percentage that reflected the time and cost spent on one jurisdictional objection pursued by Australia that was ultimately not successful.

Australia’s costs claim was reasonable

The Tribunal found that Australia had claimed a reasonable amount of costs, and rejected PMA’s argument that the figure Australia was claiming was too high. The Tribunal took into account the complexity and length of the dispute, and the fact that it was Australia’s first investment arbitration, which meant that Australia had had to hire external counsel and develop in-house capacity and procedures from scratch.

The Tribunal also emphasised that Australia’s expenditure was appropriate given the significance of the case:

“In making this assessment, the Tribunal also takes into consideration the significant stakes involved in this dispute in respect of Australia’s economic, legal and political framework, and in particular the relevance of the outcome in respect of Australia’s policies in matters of public health.”

The Tribunal issued a redacted costs award ordering PMA to pay an undisclosed sum to Australia, and awarding interest of 1.5% (the Reserve Bank of Australia’s cash rate) on the total sum.

Status of disputes

The decision brings the investment proceedings against Australia’s plain packaging laws, which were initiated in 2011, to a close. A constitutional challenge was dismissed in 2012, and a WTO panel decision is still pending.

Cross posted from the McCabe Centre Knowledge Hub site

Recent Posts

Farewell to our Regional Manager for the Pacific, Daiana Buresova

After almost a decade with the McCabe Centre for Law and Cancer, Daiana Buresova will this month leave her position as Regional Manager for the Pacific.
People in front of the COP sign in Panama

WHO FCTC COP moves forward with decisions on human rights, liability, the environment, digital media, and the future of tobacco control

Sunday 11 February 2024
Parties to the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) made important advances this week to fight tobacco, the world’s leading single preventable cause of death. The tenth session of the Conference of the Parties (COP10) to the WHO FCTC featured a packed agenda, and the COP adopted a number of important decisions.
Alcohol Bottles

How Ireland beat the odds to introduce cancer warning labels on alcohol

Monday 5 February 2024
Despite opposition from industry groups at home and internationally, Ireland will soon be the first country to warn drinkers of the links between cancer and any alcohol consumption on the drinks label. How did Ireland beat the odds to introduce these labels? Clare Slattery takes a closer look in this piece for World Cancer Research Fund.

Closing the care gap on World Cancer Day

Friday 2 February 2024
This World Cancer Day, we’re joining the call to address the cancer care gap, and allow everyone access to safe, affordable cancer treatment and care.

Take a look back at 2023 with us

Thursday 21 December 2023
It's been another big year for the McCabe Centre for Law and Cancer. Last year we celebrated our tenth anniversary, and in 2023 we celebrate ten years as the WHO FCTC Knowledge Hub on Legal Challenges.